{
  "name": "Hyperbaric Oxygen Chamber (HBOT)",
  "category": "device",
  "evidenceGrade": "B",
  "riskProfile": "medium",
  "description": "Pressurized chamber delivering 100% oxygen at 1.3-2.0 ATA. Increases dissolved oxygen in plasma, stimulates stem cell release, promotes angiogenesis, and has shown remarkable results in reversing biological aging markers in clinical trials.",
  "mechanisms": [
    "Hyperoxia-hypoxia paradox (stem cell mobilization)",
    "Telomere lengthening",
    "Senescent cell clearance",
    "Angiogenesis and neuroplasticity"
  ],
  "dosage": {
    "standard": "60-90min at 1.5-2.0 ATA, 2-5x/week",
    "range": "40-120min sessions",
    "notes": "Clinical HBOT at 2.0 ATA requires prescription. Mild HBOT (1.3 ATA) available for home use. Tel Aviv protocol: 60 sessions for anti-aging."
  },
  "keyFindings": [
    "Lengthened telomeres by 20-38% and cleared senescent cells by 11-37% (Hadanny 2020, Tel Aviv)",
    "Improved cognitive function in elderly with MCI in randomized trial",
    "FDA-approved for 14 conditions including wound healing and carbon monoxide poisoning"
  ],
  "interactions": [
    "Certain chemotherapy drugs",
    "Bleomycin (pulmonary toxicity risk)"
  ],
  "sideEffects": [
    "Ear barotrauma",
    "Sinus pressure",
    "Temporary myopia",
    "Claustrophobia"
  ],
  "contraindications": [
    "Untreated pneumothorax",
    "Certain lung conditions",
    "Recent ear surgery"
  ],
  "tags": [
    "device",
    "oxygen",
    "telomere",
    "senolytic",
    "regeneration",
    "clinical"
  ],
  "estimatedMonthlyCost": {
    "low": 200,
    "mid": 600,
    "high": 1500,
    "currency": "USD"
  },
  "id": "prod-hyperbaric-oxygen-chamber-hbot",
  "sources": [],
  "suppliers": [],
  "communityReports": [],
  "expertOpinions": [],
  "lastUpdated": "2026-02-04T14:50:14.802Z",
  "createdAt": "2026-02-04T14:50:14.802Z"
}